EE200200362A - Diazepine carboxamide derivatives, their preparation and use as pharmaceuticals, and pharmaceutical compositions containing them - Google Patents

Diazepine carboxamide derivatives, their preparation and use as pharmaceuticals, and pharmaceutical compositions containing them

Info

Publication number
EE200200362A
EE200200362A EEP200200362A EEP200200362A EE200200362A EE 200200362 A EE200200362 A EE 200200362A EE P200200362 A EEP200200362 A EE P200200362A EE P200200362 A EEP200200362 A EE P200200362A EE 200200362 A EE200200362 A EE 200200362A
Authority
EE
Estonia
Prior art keywords
pharmaceuticals
preparation
pharmaceutical compositions
compositions containing
carboxamide derivatives
Prior art date
Application number
EEP200200362A
Other languages
Estonian (et)
Inventor
Bhatnagar Neerja
Mauger Jacques
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9553901&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200200362(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of EE200200362A publication Critical patent/EE200200362A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention concerns products of formula (I) wherein: R1 represents in particular -C(O) -R5, -SO2 -R5 or -C(O) -NR6R5, R2 and R7 are such that either R7 represents a hydrogen atom and R2 is such that the group (a) represents the radical of a natural or non-natural amino acid, or R2 and R7 form together a cycle with the nitrogen and carbon atom whereto they are bound, R3 represents in particular the radical -CH=N2 or -CH2-L-R4, R4 represents in particular a linear or branched alkyl radical, and their additive salts with mineral or organic acids or with mineral or organic bases of said products of formula (I). The invention also concerns the method for preparing said products and their use as medicines.
EEP200200362A 1999-12-28 2000-12-21 Diazepine carboxamide derivatives, their preparation and use as pharmaceuticals, and pharmaceutical compositions containing them EE200200362A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9916567A FR2802927B1 (en) 1999-12-28 1999-12-28 NOVEL DIAZEPINE CARBOXAMIDE DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND THEIR NEW USE
PCT/FR2000/003622 WO2001047930A1 (en) 1999-12-28 2000-12-21 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof

Publications (1)

Publication Number Publication Date
EE200200362A true EE200200362A (en) 2003-08-15

Family

ID=9553901

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200362A EE200200362A (en) 1999-12-28 2000-12-21 Diazepine carboxamide derivatives, their preparation and use as pharmaceuticals, and pharmaceutical compositions containing them

Country Status (26)

Country Link
EP (1) EP1246824B1 (en)
JP (1) JP2003519152A (en)
KR (1) KR20020062772A (en)
AT (1) ATE268775T1 (en)
AU (1) AU780522B2 (en)
BR (1) BR0016845A (en)
CA (1) CA2395275A1 (en)
DE (1) DE60011473T2 (en)
DK (1) DK1246824T3 (en)
EA (1) EA005288B1 (en)
EE (1) EE200200362A (en)
ES (1) ES2218275T3 (en)
FR (1) FR2802927B1 (en)
HR (1) HRP20020558A2 (en)
HU (1) HUP0203921A3 (en)
IL (1) IL150419A0 (en)
MX (1) MXPA02006413A (en)
NO (1) NO20023107L (en)
NZ (1) NZ519884A (en)
PL (1) PL355950A1 (en)
PT (1) PT1246824E (en)
SI (1) SI1246824T1 (en)
SK (1) SK9092002A3 (en)
WO (1) WO2001047930A1 (en)
YU (1) YU47502A (en)
ZA (1) ZA200205221B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220115062A (en) 2021-02-09 2022-08-17 (주)오스티오뉴로젠 Pharmaceutical Composition For Treating and Preventing Osteoporosis Comprising Compounds of Chromone Scaffold

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5552400A (en) * 1994-06-08 1996-09-03 Sterling Winthrop Inc. Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors
US5847135A (en) * 1994-06-17 1998-12-08 Vertex Pharmaceuticals, Incorporated Inhibitors of interleukin-1β converting enzyme

Also Published As

Publication number Publication date
NO20023107L (en) 2002-08-27
FR2802927A1 (en) 2001-06-29
CA2395275A1 (en) 2001-07-05
ATE268775T1 (en) 2004-06-15
PT1246824E (en) 2004-10-29
NZ519884A (en) 2005-03-24
EP1246824B1 (en) 2004-06-09
MXPA02006413A (en) 2002-11-29
HUP0203921A2 (en) 2003-03-28
PL355950A1 (en) 2004-05-31
BR0016845A (en) 2002-10-15
DE60011473D1 (en) 2004-07-15
DK1246824T3 (en) 2004-10-18
EP1246824A1 (en) 2002-10-09
IL150419A0 (en) 2002-12-01
WO2001047930A1 (en) 2001-07-05
YU47502A (en) 2005-03-15
SI1246824T1 (en) 2004-10-31
ES2218275T3 (en) 2004-11-16
SK9092002A3 (en) 2003-04-01
AU780522B2 (en) 2005-03-24
EA005288B1 (en) 2004-12-30
DE60011473T2 (en) 2005-06-30
AU2688801A (en) 2001-07-09
HUP0203921A3 (en) 2005-01-28
ZA200205221B (en) 2003-09-04
EA200200721A1 (en) 2002-12-26
FR2802927B1 (en) 2002-03-01
JP2003519152A (en) 2003-06-17
HRP20020558A2 (en) 2004-02-29
KR20020062772A (en) 2002-07-29
NO20023107D0 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
BR0114436A (en) Five element ring compound containing aliphatic nitrogen
EA200400944A1 (en) SUBSTITUTED TETRACYCLINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING THE SUBJECT WITH THEIR USE
NZ324007A (en) Quinazoline derivatives susbtituted by a phenyl and medicaments
DE69628466D1 (en) Intermediate compounds for the preparation of new pyridonecarboxylic acid derivatives or their salts
UY25679A1 (en) QUINOLIN-2-ONA DERIVATIVES FARNESIL PROTEIN TRANSFER INHIBITORS USEFUL AS AGENTS AGAINST CANCER
RS49906B (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
MX9504287A (en) Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents.
NO924929L (en) PHARMASOEYTIC ACTIVE BENZOQUINAZOLINE COMPOUNDS
MXPA03000547A (en) Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder.
BR0006299A (en) Derivatives of 4-oxo-2-urea-1,4,5,6-tetrahydro-pyrimidine
MXPA01013148A (en) Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use.
EE200200362A (en) Diazepine carboxamide derivatives, their preparation and use as pharmaceuticals, and pharmaceutical compositions containing them
ES2131549T3 (en) 16-LINK MACROLID DERIVATIVES AND THEIR PREPARATION PROCEDURE.
RS50423B (en) Novel octahydro-6,10-dioxo-6h-pyridazino(1,2-a)diazepin -1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds
EA200101170A1 (en) HALOGEN DERIVATIVES 9-DEOXO-9A-AZA-9A-Homoeritromycin A
AP9901566A0 (en) Novel erythromycin derivatives, method of preparation and application as medicines.
CA2296984A1 (en) Composition for topical application to the skin and/or skin appendages, comprising at least one compound containing a phenyloxime fragment
PE20080699A1 (en) AZALIDAS 9A-SUBSTITUTED WITH ANTIMALARIC ACTIVITY
HUP0002727A2 (en) Methods for reducing fibrinogen using benzotiophene derivatives
IT1205114B (en) 2-SELENOMETHYL-1,4-DIHYDROPYRIDINE, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NZ509327A (en) Alpha-amino acid phenyl ester derivatives for use in general anaesthesia
DE69902821T2 (en) 4'-SUBSTITUTED-4 ', 5'-DIHYDROPSORALENES AND THEIR THERAPEUTIC USE